MDL 72222, ketanserin, and methysergide pretreatments fail to alter breaking points on a progressive ratio schedule reinforced by intravenous cocaine
- 1 January 1993
- journal article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 44 (1) , 161-165
- https://doi.org/10.1016/0091-3057(93)90295-5
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- MDL72222, a serotonin 5-HT3 receptor antagonist, blocks MDMA's ability to establish a conditioned place preferencePharmacology Biochemistry and Behavior, 1991
- Activation of 5-HT3 receptor by 1-phenylbiguanide increases dopamine release in the rat nucleus accumbensBrain Research, 1991
- Subtypes of Receptors for SerotoninAnnual Review of Pharmacology and Toxicology, 1990
- Blockade of acquisition of drug-conditioned place aversion by 5HT3 antagonistsPsychopharmacology, 1990
- Intravenous cocaine self-administration in rats is reduced by dietaryl-tryptophanPsychopharmacology, 1990
- Fluoxetine reduces intravenous cocaine self-administration in ratsPharmacology Biochemistry and Behavior, 1990
- 5HT3 receptor antagonists block morphine- and nicotine-but not amphetamine-induced rewardPsychopharmacology, 1989
- 5-HT3 receptors antagonists block morphine- and nicotine- but not amphetamine-induced place-preference conditioningPharmacological Research Communications, 1988
- Activation of a 5-HT3 receptor releases dopamine from rat striatal sliceEuropean Journal of Pharmacology, 1988
- Neuropharmacological reassessment of the discriminative stimulus properties ofd-lysergic acid diethylamide (LSD)Psychopharmacology, 1987